Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
In Vitro and in Vivo Anti-Parasitic Activity of Biogenic Antimony Sulfide Nanoparticles on Leishmania Major (Mrho/Ir/75/Er) Publisher Pubmed



Mohtasebi S1, 2 ; Mohebali M1, 3 ; Elikaee S1 ; Akhoundi B1 ; Foroushani AR4 ; Teimouri A1 ; Yarizadeh H1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Students Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Research Center for Endemic Parasites, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Source: Parasitology Research Published:2019


Abstract

The aims of this study were to produce biogenic antimony sulfide nanoparticles (NPs) using Serratia marcescens (S. marcescens) and investigate the potential anti-leishmanial effects of these NPs on Leishmania major (L. major) (MRHO/IR/75/ER) in both in vitro and in vivo experiments. Biogenic antimony sulfide NPs were synthesized through intracellular biological methods using S. marcescens. The efficiency of various concentrations of antimony sulfide NPs was assessed using in vitro experiments on amastigotes of L. major at various times post-infection. In vivo experiments were carried out in BALB/c mice inoculated subcutaneously with 2 × 106L. major promastigotes (MHROM/IR/75/ER) and treated with antimony sulfide NPs (70 μg/mL, tropically), meglumine antimoniate (glucantime) as positive control and sterile phosphate-buffered saline (PBS, pH 7.4) as vehicle control. Results of in vitro experiments revealed that the anti-leishmanial activity increased when the antimony sulfide NPs concentration increased. The IC50 (50% inhibitory concentration) of antimony sulfide NPs against amastigotes was calculated as 62.5 μg/mL. In in vivo experiments, the average size of lesions significantly decreased to 8.6 ± 2.7 mm2 in mice inoculated with L. major promastigotes and treated with antimony sulfide NPs, compared with that in the negative control group (P = 0.015). Furthermore, results showed that antimony sulfide NPs significantly decreased the parasite load in the test group, compared with the negative control group (P = 0.001). Various concentrations of antimony sulfide NPs showed a great anti-leishmanial efficiency against L. major (MRHO/IR/75/ER), with the greatest efficiency shown by a concentration of 62.5 μg/mL in in vitro and in vivo experiments. © 2019, Springer-Verlag GmbH Germany, part of Springer Nature.
Related Docs
View other Related Docs
1. Novel Strategies and Pharmaceutical Agents for the Treatment of Leish-Maniasis: A Review, Anti-Infective Agents (2020)
2. Antileishmanial Activities of (Z)-2-(Nitroimidazolylmethylene)-3 (2H)-Benzofuranones: Synthesis, in Vitro Assessment, and Bioactivation by Ntr 1 and 2, Antimicrobial Agents and Chemotherapy (2022)
3. Development of a Topical Liposomal Formulation of Amphotericin B for the Treatment of Cutaneous Leishmaniasis, International Journal for Parasitology: Drugs and Drug Resistance (2019)
4. Bioengineering of Nanomaterials Using Biological Resources: Biofabrication Mechanisms, Characterizations, and Biomedical Applications, Bioengineered Nanomaterials for Wound Healing and Infection Control (2023)
5. Metal, Metalloid, and Oxide Nanoparticles for Therapeutic and Diagnostic Oncology, Nano Biomedicine and Engineering (2016)
6. The Therapeutic Efficacy of Zinc Oxide Nanoparticles on Acute Toxoplasmosis in Balb/C Mice, Iranian Journal of Parasitology (2023)
7. The Determination of Biomass/Selenium Ratio and the Impact of Glucose and Piperitone Upon Selenium Ion Reduction Using Bacillus Sp. Msh-1 Whole Cells, Nano Biomedicine and Engineering (2017)
8. Antimonial Treatment Failure Rate in Patients With Cutaneous Leishmaniasis, Tehran University Medical Journal (2018)
Experts (# of related papers)
View all Related Experts
Mahdi Mohebali (15)
Saeedeh Shojaee (6)
Other Related Docs
9. Anti-Toxoplasma Activity of Various Molecular Weights and Concentrations of Chitosan Nanoparticles on Tachyzoites of Rh Strain, International Journal of Nanomedicine (2018)
10. Determination of the Effective Dose of Curcumin Alone and in Combination With Antimicrobial Peptide Cm11 on Promastigote Forms of Iranian Strain of L. Major (Mrho / Ir / 75 / Er); [Determination De La Dose Efficace De Curcumine Seule Et En Association Avec Le Peptide Antimicrobien Cm11 Sur La Forme Promastigote De La Souche Iranienne Leishmania Major (Mrho/Ir/75/Er)], Archives of Razi Institute (2019)
11. Unravelling Toxoplasma Treatment: Conventional Drugs Toward Nanomedicine, World Journal of Microbiology and Biotechnology (2021)
12. Correlation Between Clinical Responses With the Drug-Susceptibility of Parasites in Iranian Cutaneous Leishmaniasis Caused by Leishmania Major, Tropical Biomedicine (2017)
13. Field Efficacy of Topical Nano-Liposomal Amphotericin B (Sina Ampholeish®) Alone or in Combination With Glucantime® and Cryotherapy on Human Cutaneous Leishmaniasis, Iranian Journal of Parasitology (2023)
14. Amphotericin B-Loaded Extracellular Vesicles Derived From Leishmania Major Enhancing Cutaneous Leishmaniasis Treatment Through in Vitro and in Vivo Studies, Iranian Journal of Parasitology (2023)
15. Gene Expression Analysis of Antimony Resistance in Leishmania Tropica Using Quantitative Real-Time Pcr Focused on Genes Involved in Trypanothione Metabolism and Drug Transport, Archives of Dermatological Research (2019)
16. Antileishmanial Activity of Allium Hirtifolium on Promastigote and Amastigote Developmental Stages of the Parasite, Leishmania Major, Medicinal Plants (2020)
17. A Review on the Use of Essential Oil-Based Nanoformulations in Control of Mosquitoes, Biointerface Research in Applied Chemistry (2021)
18. Biogenic Selenium Nanoparticles Target Chronic Toxoplasmosis With Minimal Cytotoxicity in a Mouse Model, Journal of Medical Microbiology (2020)
19. Prophylactic Activity of Biogenic Selenium Nanoparticles Against Chronic Toxoplasma Gondii Infection, Recent Patents on Anti-Infective Drug Discovery (2020)
20. Development of Topical Liposomes Containing Miltefosine for the Treatment of Leishmania Major Infection in Susceptible Balb/C Mice, Acta Tropica (2019)
21. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 301 Acute and Chronic Diseases and Injuries in 188 Countries, 1990-2013: A Systematic Analysis for the Global Burden of Disease Study 2013, The Lancet (2015)
22. Formulation and Evaluation of Atovaquone-Loaded Macrophage-Derived Exosomes Against Toxoplasma Gondii: In Vitro and in Vivo Assessment, Microbiology Spectrum (2024)
23. Sambucus Ebulus Extract Stimulates Cellular Responses in Cutaneous Leishmaniasis, Parasite Immunology (2019)
24. Antimicrobial Activity of an Antimicrobial Peptide Against Amastigote Forms of Leishmania Major, Veterinary Research Forum (2018)
25. Presence and Diversity of Leishmania Rna Virus in an Old Zoonotic Cutaneous Leishmaniasis Focus, Northeastern Iran: Haplotype and Phylogenetic Based Approach, International Journal of Infectious Diseases (2020)
26. Niosomal Formulation of Amphotericin B Alone and in Combination With Glucantime: In Vitro and in Vivo Leishmanicidal Effects, Biomedicine and Pharmacotherapy (2019)
27. Study on Knowledge, Attitude and Practice of Health Workers of East Azerbaijan, Ilam and Khorasan Razavi Provinces About Leishmaniasis During 2015-2016: A Comparative Study Before and After Intervention, Archives of Clinical Infectious Diseases (2019)
28. Protoscolicidal Effects of Curcumin Nanoemulsion Against Protoscoleces of Echinococcus Granulosus, BMC Complementary Medicine and Therapies (2023)
29. Economic Burden of Cutaneous and Visceral Lishmaniasis in Iran in 2013, Iranian Journal of Epidemiology (2017)
30. Spatio-Temporal Analysis of Cutaneous Leishmaniasis Using Geographic Information System Among Iranian Army Units and Its Comparison With the General Population of Iran During 2005–2014, Journal of Parasitic Diseases (2017)
31. Multi-Antigen Vaccination With Lpd Nanoparticles Containing Rgp63 and Rlmac1n Proteins Induced Effective Immune Response Against Leishmaniasis in Animal Model, Journal of Drug Delivery Science and Technology (2021)
32. Nanoemulsion of Spiramycin Against Tachyzoites of Toxoplasma Gondii, Rh Strain: Preparation, Toxicology, and Efficacy Studies, Iranian Journal of Public Health (2023)
33. Aerobic Bacterial Flora of Biotic and Abiotic Compartments of a Hyperendemic Zoonotic Cutaneous Leishmaniasis (Zcl) Focus, Parasites and Vectors (2015)
34. Relationship Between the Distribution and Biodiversity of Sand Flies (Diptera: Psychodidae) With the Incidence of Zoonotic Cutaneous Leishmaniasis in Endemic Foci of Golestan Province, Iran, Journal of Medical Entomology (2020)
35. Double-Blind Randomized Efficacy Field Trial of Alum Precipitated Autoclaved Leishmania Major (Alum-Alm) Vaccine Mixed With Bcg Plus Imiquimod Vs. Placebo Control Group, Iranian Journal of Parasitology (2015)
36. History of Medical Parasitology and Parasitic Infections in Iran, Archives of Iranian Medicine (2016)
37. The Therapeutic Effects of Olive Leaf Extract on Leishmania Major Infection in Balb/C Mice, Marmara Pharmaceutical Journal (2017)
38. The Role of Lpd-Nanoparticles Containing Recombinant Major Surface Glycoprotein of Leishmania (Rgp63) in Protection Against Leishmaniasis in Murine Model, Immunopharmacology and Immunotoxicology (2018)
39. Effects of Combined Therapy With Silymarin and Glucantime on Leishmaniasis Induced by Leishmania Major in Balb/C Mice, Drug Research (2015)
40. Epidemiological Aspects of Cutaneous Leishmaniasis in Iran, Archives of Clinical Infectious Diseases (2015)